In a recent study published in the Proceedings of the National Academy of Sciences, researchers explored the shortcomings in mucosal immunoglobulin A (IgA) responses induced by existing vaccines ...
“Our results show how different factors boost the formation of antibodies that broadly combat different viral strains. This will pave the way for us to systematically push ahead with the development ...
Key market opportunities in the antibody optimization service industry include addressing rising chronic and complex diseases ...
An HIV vaccine candidate developed at the Duke Human Vaccine Institute (DHVI) triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a ...
(A) Cryo-EM structure overview of HSV-1 gB in complex with D48 Fab. The side view and top view were presented. The HSV-1 gB trimer and D48 Fab VH/VL were colored differently. (B) Neutralization assay ...
Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...
When some viruses infect our bodies, “our immune system can create a type of ‘permanent immunity’, meaning that once you’ve been exposed to that virus, you’ve got protection from it and are typically ...
Remember the 2016 Olympics in Brazil? It was the year Brazil defeated Germany in the final game of the men's football (aka soccer) tournament, but it was also the year when Zika virus made its entry ...
Rapid Novor Inc., the world's leader in mass spectrometry (MS)-based antibody sequencing, published a peer-reviewed research article where REpAb ® antibody discovery platform was used to sequence a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback